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B7/CD28 Costimulation Is Essential for the
Homeostasis of the CD41CD251 Immunoregulatory
T Cells that Control Autoimmune Diabetes
absence of CD28 signaling (Shahinian et al., 1993; Kun-
dig et al., 1996). CD28 blockade has been shown to
prevent or delay graft rejection and, in some instances,
results in the development of donor-specific tolerance
(Lenschow et al., 1996a). Recent studies have implicated
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Canada lation was blocked during the priming with the relevant
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mice and transgenic NOD mice that express soluble
circulating CTLA4Ig, a molecule that binds with high
affinity to B7 molecules and blocks B7 costimulation,Summary
have increased severity of this autoimmune disease
(Lenschow et al., 1996b).CD28/B7 costimulation has been implicated in the in-
duction and progression of autoimmune diseases. Ex- Multiple differences may account for the discrepancy
between the results in the NOD model of spontaneousperimentally induced models of autoimmunity have
been shown to be prevented or reduced in intensity autoimmunity and other experimentally induced autoim-
munity models. First, contrary to experimental autoim-in mice rendered deficient for CD28 costimulation. In
sharp contrast, spontaneous diabetes is exacerbated mune diseases induced after a single injection of the
relevant self-antigen (usually in a proinflammatory adju-in both B7-1/B7-2-deficient and CD28-deficient NOD
mice. These mice present a profound decrease of the vant such as CFA), the spontaneous diabetes observed
in the NOD mice is a consequence of chronic exposuresimmunoregulatory CD41CD251 T cells, which control
diabetes in prediabetic NOD mice. These cells are ab- to the pathogenic self-antigens, where CD28 costimula-
tion has been shown to be less critical. Indeed, it hassent from both CD28KO and B7-1/B7-2KO mice, and
the transfer of this regulatory T cell subset from control been reported in CD28-deficient mice that short-term
TCR stimulation induced anergy of T cells, whereas pro-NOD animals into CD28-deficient animals can delay/
prevent diabetes. The results suggest that the CD28/ longed TCR stimulation induced a functional T response
in vivo (Kundig et al., 1996). This may explain why CD28B7 costimulatory pathway is essential for the develop-
ment and homeostasis of regulatory T cells that con- is dispensable in spontaneous autoimmune diabetes.
However, the relative CD28 independence of this re-trol spontaneous autoimmune diseases.
sponse cannot account for the exacerbation of disease
in the CD28-deficient setting. Second, as we have pre-Introduction
viously shown, the increase of diabetes in CD28-defi-
cient NOD mice could be due to a lack of autoreactiveThe nonobese diabetic (NOD) mouse strain remains the
best available model for the study of insulin-dependent Th2-type T cells (Lenschow et al., 1996b). Indeed, the
Th1/Th2 balance of autoreactive T cells has been showntype I diabetes mellitus. This mouse strain develops
a complex autoimmunity controlled by multiple genes to regulate the disease, as Th2 cytokines have protective
including those syntenic with genetic loci controlling effects in this model (King and Sarvetnick, 1997). Finally,
susceptibility in humans (Todd, 1997). Thus, attempts CD28 has been shown to upregulate the expression of
to define the basic immune pathology and regulation of the negative regulatory CD28 homolog CTLA-4 (Alegre
this disease in mice are likely to have important implica- et al., 1996; Finn et al., 1997). CTLA-4-deficient mice die
tions for the understanding and treatment of the human of a massive lymphoproliferation resembling a general-
disease. Over the past few years, we and others have ized autoimmune disease (Tivol et al., 1995), and CTLA-4
shown that the B7/CD28 costimulatory pathway is a has been shown to play a role in T cell peripheral
major regulatory pathway for the control of immune re- tolerance (Perez et al., 1997). Blocking the B7/CTLA-4
sponses (Bluestone et al., 1999). T-dependent antibody interaction during an ongoing autoimmune process can
responses are severely impaired and induction of CTL exacerbate experimental autoimmune encephalomyeli-
to short term antigen exposure greatly reduced in the tis (Karandikar et al., 1996). Significantly, short-term
therapy with anti-CTLA-4 mAbs of a diabetogenic T cell
receptor transgenic mouse strain results in rapid induc-§ To whom correspondence should be addressed (e-mail: jbluest@
immunology.uchicago.edu). tion of insulitis and b cell destruction (Luhder et al.,
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Figure 1. Increased Incidence and Early Onset of Diabetes in B7-Deficient NOD Mice
Blood glucose levels were checked weekly in B7-deficient (B72/2, closed circles), B7 heterozygous (B71/2, dashed line) and B7 wild-type
(B71/1, open circles) females (left) and males (right). Ten to twenty-seven mice were analyzed per group.
1998). Finally, CTLA-4 polymorphisms have been impli- by 18 weeks of age. The disease onset was earlier and
more severe as compared to their littermate B71/1 con-cated as a risk factor in the development of human
diabetes mellitus (Donner et al., 1997; Marron et al., trols (Figure 1). Interestingly, the incidence of diabetes
in heterozygote B71/2 mice was significantly increased1997). Thus, the blockade of CD28 might alter CTLA-4,
affecting immune regulation in this model. over that seen in the B71/1 animals (Figure 1). Flow
cytometric analyses showed that both B7-1 and B7-2To further analyze the role of B7 costimulation in auto-
immune diabetes, we bred B7-1/B7-2-deficient mice were expressed at lower levels on resting and in vitro
activated B cells, dendritic cells, and CD41 and CD81 Tinto the NOD background. B7-1 (CD80) and B7-2 (CD86)
molecules are the only two ligands of CD28 and CTLA-4; cells isolated from B71/2 mice as compared to cells
from B71/1 littermate mice (data not shown). Thus, boththus, B7-deficient mice have a complete deficit in
CD28 and CTLA-4 signaling. In the present study, we alleles of B7-1 and B7-2 genes are functionally active
and contribute to the overall level of B7 expression.show that B7-1/B7-2-deficient mice develop a more se-
vere diabetes as compared to control mice. The disease These results suggest that a 50% decrease on B7 ex-
pression can dramatically alter the progression of auto-was not associated with a shift of the Th1/Th2 balance.
Rather, the B7-1/B7-2-deficient NOD mice present with immunity in these animals.
a profound decrease of a regulatory CD41CD251 T cell
population. Not only are these cells absent from both Both Th1 and Th2 Cytokines Are Reduced
CD28-deficient and B7-1/B7-2-deficient mice, but trans- in B7-Deficient NOD Mice
fer of the regulatory T cell subset from control NOD The role of cytokines in autoimmune diabetes has been
animals into CD28-deficient animals can delay/prevent extensively studied in NOD mice. Some cytokines, such
diabetes. The results suggest that the CD28/B7 costimu- as IFNg, are pathogenic, whereas others, like IL-4 or
latory pathway is essential for the development and ho- TGFb, could block the development of the disease (King
meostasis of the regulatory T cells that control sponta- and Sarvetnick, 1997; King et al., 1998). The differentia-
neous autoimmune diseases. tion of Th2 cells secreting IL-4, IL-5, and IL-10 requires
B7/CD28 costimulation (Rulifson et al., 1997). In fact,
CD28-deficient NOD mice have impaired Th2 differentia-Results
tion while Th1 development is maintained (Lenschow
et al., 1996b). These results suggested that an imbalanceIncreased Incidence of Diabetes in
B7-1/B7-2-Deficient NOD Mice in Th1/Th2 differentiation, as evidenced in the CD28-
deficient NOD mice, might be a possible mechanismA genetic approach was used to analyze the role of B7
costimulatory molecules in autoimmune diabetes. B7- for the exacerbation of diabetes observed in the B7-
deficient NOD mice. Thus, T cells from B7-deficient mice1/B7-2 double-deficient (B72/2) mice were bred into the
NOD background. Diabetes was assessed by weekly were stimulated with anti-CD3 mAbs, and supernatants
were harvested to determine the levels of IL-4, IL-5, andmeasurement of urinary glucose or blood glucose con-
centrations. After four generations of backcrosses, IFNg production. First, unlike the CD28-deficient NOD
mice (Lenschow et al., 1996b), the production of all cyto-some but not all the diabetic susceptibility genes were
fixed as only 40% of female wild type (B71/1) and less kines was significantly reduced as compared to cyto-
kines produced by T cells from wild-type mice (Figurethan 10% of male B71/1 mice became diabetic by 24
weeks of age as compared to 70% of females and 20% 2A). In addition, isotype analysis of antibodies to glu-
tamic acid decarboxylase (GAD), a potent autoantigenof males in our wild type NOD colony. However, despite
the incomplete breeding to the NOD background, almost in autoimmune diabetes, showed that overall levels of
antibodies were reduced in the serum of B7-deficient100% of female and male B72/2 mice became diabetic
CD28 Controls Regulatory T Cell Homeostasis
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Figure 2. Both Th1 and Th2 Responses Are Reduced in B7-Deficient Mice
(A) Cytokines produced by T cells stimulated as described in the Experimental Procedures were measured by ELISA. Two B72/2 females and
three littermate B71/1 females were analyzed in this experiment, which is representative of three independent experiments. Cells from males
and females produced similar levels of cytokines.
(B) Reduced anti-GAD67 antibody levels in the sera of B7-deficient NOD mice. Anti-GAD67 IgG antibody, anti-GAD67 IgG1, and anti-GAD67
IgG2b isotypes in the sera of individual male and female B71/1 and B72/2 NOD mice were measured by ELISA as described in the Experimental
Procedure. The results are presented as OD at 1:20 dilution of the sera.
NOD mice and that the levels of the Th1-dependent animals. No insulitis was detected at 4 weeks of age
and even at 6 weeks most of islets were not infiltrated.IgG2b isotype were severely decreased in these mice
(Figure 2B). The Th2-dependent, IgG1 isotype was more However, a rapid increase in the levels of islet infiltration
was observed by 9 weeks of age (Figure 3B; data notvariable. The levels of GAD-specific IgG1 antibodies
were significantly reduced in five out of nine mice, but shown). The increased islet infiltration was not progres-
sive as in control NOD mice but occurred rapidly be-the serum levels of anti-GAD IgG1 antibodies were com-
parable to wild-type mice in the remaining four animals. tween 7 and 9 weeks of age. The accelerated kinetics
of islet infiltration in B7-deficient mice suggested thatThus, contrary to previous observations with the CD28-
deficient NOD mice, a selective decrease in Th2 cytokine a regulatory process that normally modulates the auto-
reactivity in the pancreas is lacking in these mice. Suchproduction could not explain the increased disease se-
verity in this B7-deficient NOD strain. a regulatory mechanism has been postulated in NOD
mice based on the normally protracted time between
the first appearance of insulitis (checkpoint 1) and theB7-Deficient NOD Mice Develop a Rapid Progression
of Insulitis at 7±9 Weeks of Age progression to frank diabetes (checkpoint 2) (Andre et
al., 1996).In order to better understand the pathogenesis of the
disease, a careful study of the insulitis in B7-deficient
NOD mice was undertaken. Virtually all islets isolated Expression of CTLA-4 on an Immunoregulatory
Subset of CD41 T Cells in NOD Micefrom 9-week-old prediabetic male and female B7-defi-
cient mice were highly infiltrated and scored as severe One candidate for the control of diabetes is the regula-
tion of T cell function via CTLA-4, a negative regulatoryinsulitis. This result was in stark contrast to the wild-
type NOD mice, where less than 10% of the islets from molecule on the surface of activated T cells (Walunas
et al., 1994). The engagement of this molecule has beenfemale and only 3% of the islets from male mice dis-
played a severe insulitis (Figure 3A). CD41 and CD81 T shown to control other autoimmune diseases, and the
absence of its ligands, B7-1 and B7-2, in B7-deficientcells, B2201 B cells, and CD11c1 dendritic cells infil-
trated the islets at high levels more similar to that ob- mice might account for the absence of immunoregula-
tory activity to control checkpoint 2. Therefore, T cellsserved in much older (15- to 20-week-old) control NOD
mice (data not shown). These results suggested that from NOD mice were examined for intracellular CTLA-4
expression where the majority of the CTLA-4 proteinthe disease process was highly accelerated in the B7-
deficient mice. A kinetic analysis of islet infiltration in B7- resides (Alegre et al., 1996). As seen in Figure 4, flow
cytometric analysis of T cells from NOD mice identifieddeficient mice was carried out by scoring the intensity of
insulitis at different time points in young prediabetic a small population of CTLA-41 T cells in the spleen and
Immunity
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Figure 3. Increased Incidence and Rapid Progression of Insulitis in B7-Deficient NOD Mice
(A) Insulitis in 9-week-old B72/2 and littermate B71/1 control females (F) and males (M) were scored for the presence of peri-insulitis, moderate
insulitis, and severe insulitis. Four mice and at least 100 islets for each group were scored, except for the male B71/1 where two mice and
65 islets were scored. Insulitis is reported as the percentage of infiltrated islets per total islets.
(B) Kinetics of insulitis in B72/2 female and male mice. Two animals (25±55 islets for females and 15±120 islets for males) from each time
point were scored. Insulitis is reported as the percentage of infiltrated islets per total islets.
lymph nodes. The T cells were shown further to be small of nondepleted splenocytes (Figure 5). These results sug-
gest that a population of small CTLA-41CD251CD41 Tin size and express CD25 constitutively.
Previous studies have demonstrated the existence of cells are present in NOD mice that control the severity
and temporal incidence of diabetes.regulatory CD41CD251 T cells that can prevent or limit
autoimmunity. In the absence of this regulatory subset,
normal mice develop several types of autoimmune dis- Absence of Immunoregulatory CD41CD251 T Cells
in B7-Deficient NOD Miceease spontaneously (Asano et al., 1996; Suri-Payer et
al., 1998; Itoh et al., 1999). In most mouse strains, this The possibility that B7 expression might affect the regu-
latory CD41CD251CTLA-41 T cells in NOD mice wassubset represents 7%±10% of the CD41 T cell subset.
In NOD mice, these cells are reduced in number, repre- examined by flow cytometric analyses of this subset. A
profound decrease of CD41CD251 T cells was observedsenting only 5%±6% of CD41 T cells (Figure 6A). An
adoptive transfer model was used to examine the role in the B72/2 NOD mice as early as 2 weeks of age and
lasted for as long as analyzed (Figure 6A). Less than 1%of the CD41CD251 T cell subset in the regulation of
autoimmune diabetes. Thirty million total splenocytes of CD41 T cells expressed CD25 as compared to 5.4% in
littermate B71/1 controls, corresponding to a 5- to 6-foldor CD25-depleted splenocytes from 11-week-old predi-
abetic NOD mice were transferred into lymphocyte-defi- decrease of the absolute number of the CD41CD251 T
cells in the B72/2 NOD, since the numbers of CD41 Tcient NOD.SCID mice. Whereas 5 out of 14 mice trans-
ferred with total splenocytes became diabetic beginning cells were similar in B72/2 and B71/1 NOD mice (data
not shown). There was also a partial decrease (37%) of9 weeks after the cell transfer, virtually all of the recipi-
ents of CD25-depleted splenocytes, including the one this subset in B71/2 heterozygotes (Figure 6A). Thus,
B72/2 mice are deficient in the immunoregulatory cellsreceiving splenocytes from NOD males, developed dia-
betes within 5 weeks post transfer (Figure 5). In addition, present in wild-type NOD mice, supporting a potential
role for B7 engagement in CD41CD251 regulatory T cellin these latter mice, blood glucose levels rose from nor-
mal values (80 to 120 mg/dl) to high hyperglycemic levels development or homeostasis.
The regulation of the development or homeostasis ofof more than 300 mg/dl within 1 week, suggesting a
very rapid kinetics of islet destruction. In contrast, the CD41CD251 cells by B7 costimulation could either be
due to the absence of CD28 or CTLA-4 engagement. Toincrease of glucose levels was more gradual in recipients
CD28 Controls Regulatory T Cell Homeostasis
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Figure 4. CD41CD251 Cells Expressed Intra-
cellular CTLA-4 Constitutively
Spleen cells coexpressing CD4 and CD25
(upper panel) or expressing CD4 but not CD25
(lower panel) were gated and analyzed for
intracellular CTLA-4 expression as described
in Experimental Procedures. CTLA-4 expres-
sion was represented with shaded histo-
grams and control staining was represented
with thick lines. One representative experi-
ment of three is shown.
differentiate between these two pathways, the propor- murine CTLA4Ig, which blocks B7 costimulation. A 4-
to 5-fold decrease of CD41CD251 cells was observedtion of the regulatory T cells in CD28-deficient NOD mice
was determined. In these mice, only 1.5% of CD4 T cells within 9 days of CTLA4Ig treatment (Figure 6B), sug-
gesting a dynamic and permanent role for CD28/B7 liga-expressed CD25 compared to 6.5% in the wild-type
controls (Figure 6A; data not shown). Thus, the profound tion in the peripheral homeostasis of these cells. More-
over, the critical role for CD28 costimulation in theabsence of these cells in CD28-deficient mice was simi-
lar to that observed in the B7-deficient mice, suggesting maintenance of this subset supports the possibility of
an ongoing, active antigenic stimulus.that the B7/CD28 interaction was critical for the homeo-
stasis of these cells. In order to determine if B7/CD28 It is interesting to note that NOD mice treated with
murine CTLA4Ig between 2 and 4 weeks of age had in-costimulation is required continuously for the homeo-
stasis of this T cell subset or is required for their creased incidence and more rapid onset of autoimmune
diabetes compared to PBS-treated control mice (Figuredevelopment, wild-type NOD mice were treated with
Figure 5. CD41CD251 Regulatory Cells Control Autoimmune Diabetes
Thirty-million total splenocytes (open circles) or splenocytes depleted of CD25-expressing cells (closed circles) from 11-week-old prediabetic
female (left) or male (right) NOD mice were transferred intravenously into sex-matched NOD.SCID mice. Blood glucose levels were checked
weekly starting 2±3 weeks post transfer until 12 weeks post transfer. One representative experiment of three is shown.
Immunity
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Figure 6. Absence of CD41CD251 Cells in B7/CD28-Deficient NOD Mice
After a double staining with anti-CD4 and anti-CD25 mAbs, the percentage of CD41CD251 T cells in the spleen was analyzed by flow cytometry.
Each diamond represents an individual mouse and the bars represent the average for each group.
(A) The percentages of CD41CD251 cells were determined for B72/2 (eight mice), B71/2 littermates (six mice), B71/1 (eight mice), and CD282/2
(seven mice) NOD mice. The results from 2- to 13-week-old mice were pooled since similar data were observed at the different ages.
Comparable percentages and differences were observed in lymph nodes.
(B) The percentages of CD41CD251 cells were determined in 6- to 8-week-old NOD mice at day 9 after five injections of 100 mg murine
CTLA4Ig or PBS at days 0, 2, 4, 6, and 8. One representative experiment of two is shown. Similar changes were observed in lymph nodes.
(C) Diabetes incidence in NOD females (left) or males (right) treated every other day with 50 mg murine CTLA4Ig (closed circles) or PBS (open
circles) at 2±4 weeks of age. Blood glucose levels were checked weekly.
6C). The exacerbated diabetes of murine CTLA4Ig-treated CD41CD251 transferred mice (data not shown). Thus,
CD41CD251 NOD T cells control diabetes induced byNOD mice is very similar to that seen in B7-deficient NOD
mice (Figures 1 and 6C) and could be explained by the CD28-deficient T cells. To extend these findings, we
examined whether the transfer of a limited number ofabsence of CD41CD251 T cells in both groups.
regulatory T cells directly into whole prediabetic CD28-
deficient NOD mice could alter the progression of dis-CD41CD251 Regulatory T Cells Control Autoimmune
ease in these highly susceptible animals. All the CD28-Diabetes in CD28-Deficient NOD Mice
deficient NOD mice either injected with PBS or withTo determine if the increase of diabetes in the mice
CD41CD252 NOD T cells became diabetic by 11 weeksdeficient in B7/CD28 costimulation was due to the ab-
of age. In contrast, in four out of the six CD28-deficientsence of the CD41CD251 cells, we analyzed whether
mice, the transfer of CD41CD251 NOD T cells signifi-these regulatory T cells can prevent or delay diabetes in-
cantly delayed the development of diabetes. In twoduced by CD28-deficient T cells transferred in NOD.SCID
animals, the disease did not develop through 15 weeksmice. As expected, the majority (70%) of control re-
of age (Figure 7B). Together, these studies suggest thatcipients injected with splenocytes from diabetic CD28-
the deficit of CD41CD251 regulatory T cells is responsi-deficient mice became diabetic by 10 weeks post
ble for the exacerbation of diabetes of the B7/CD28-transfer. Importantly, CD41CD251 NOD T cells but not
deficient NOD mice.CD252 NOD T cells prevented diabetes in this setting.
Indeed, 20 out of 21 NOD.SCID mice coinjected with
CD28-deficient splenocytes and regulatory T cells were Discussion
nondiabetic at least 10 weeks post transfer (Figure 7A).
In fact, in some cases the experiment has been carried Targeting the CD28/B7 costimulatory pathway remains
among the most promising approaches to regulatingout for more than 20 weeks with no sign of diabetes in the
CD28 Controls Regulatory T Cell Homeostasis
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Figure 7. CD41CD251 Regulatory T Cells Control Diabetes Induced by CD28-Deficient T Cells
(A) Four- to ten-week-old NOD.SCID mice were coinjected with 1 3 107 splenocytes from 8- to 10-week-old diabetic CD28-deficient NOD
mice and either 1.3±2 x 105 CD41CD251 NOD T cells (open circles) or 2 3 105 CD252 NOD T cells (closed circles). As a control, NOD.SCID
mice were injected with 1 3 107 CD28-deficient splenocytes alone (closed triangles). Blood glucose levels were then checked weekly. The
data were generated from four independent experiments with a total of 12±21 mice per group. The results with both males and females were
similar and thus were pooled. (B) A total of 8 3 106 CD41CD251 NOD T cells (open circles), 8 3 106 CD41CD252 NOD T cells (closed circles),
or PBS (closted triangles) were transferred in two or three injections into CD28-deficient NOD mice (5±8 weeks of age). The figure depicts
blood glucose levels of individual mice generated from four independent experiments. The results with both males and females were similar
and thus were pooled.
autoimmune responses. The enthusiasm derives from have shown that CD28 ligation is critical for Th2 develop-
ment (Lenschow et al., 1996b; Rulifson et al., 1997) andmultiple studies demonstrating that the blockade of
CD28/B7 interactions results in inhibition of induction IL-4 is a critical regulator of autoimmunity in the NOD
mouse strain (King and Sarvetnick, 1997). However, Th1/and progression of autoimmunity in a number of experi-
mental models (Perrin et al., 1995; Bachmaier et al., Th2 skewing was not observed in B7-deficient mice. T
cells isolated from B7-deficient animals were defective1996; Shi et al., 1998; Chang et al., 1999; Peterson et
al., 1999; Tada et al., 1999). In contrast, a previous study in both IL-4 and IFNg production. Furthermore, total
IgG levels to GAD were decreased in B7-deficient micehas shown that CD28-deficient NOD mice, defective in
the CD28/B7 costimulatory pathway, have exacerbated without an obvious decrease of the IgG1/IgG2b isotype
ratio when compared to control mice.autoimmune diabetes (Lenschow et al., 1996b). CD28-
deficient mice can also mount effective immune re- One major difference between the CD28-deficient and
B7-deficient NOD models is that B7-deficient mice lacksponses in allograft rejection and some viral infections
(Kundig et al., 1996; Lin et al., 1998; Szot et al., 2000). both CD28 and CTLA-4 signaling. CTLA-4 has been im-
plicated in the regulation of autoimmunity. One of theIn contrast, B7-deficient mice are not able to reject allo-
grafts and exhibit a more severely compromised im- loci of susceptibility to autoimmune diabetes in mice
and humans is closely linked to the CTLA-4 locus (Todd,mune response than the CD28-deficient mice (Shahinian
et al., 1993; Borriello et al., 1997; Szot et al., 2000). 1997). Furthermore, the rapid death of CTLA-4-deficient
mice suggests an important role for this molecule inTherefore, B7-1/B7-2 deficient mice were bred into the
NOD background to assess the role of B7 molecules in immune tolerance (Tivol et al., 1995). However, several
pieces of evidence suggest that the absence of CTLA-4the development and progression of diabetes in this
autoimmune mouse strain. The results demonstrate that ligation (at least on the potentially diabetogenic cells)
was not the primary cause of the increase of diabetesnot only is the engagement of B7-1 and B7-2 not neces-
sary for the development of diabetes, but the absence in B7-deficient mice. First, in our hands, anti-CTLA-4
antibody treatment (using a regimen known to causeof this costimulatory ligation results in exacerbation of
autoimmunity. enhanced immunity in other autoimmune settings [Karan-
dikar et al., 1996]) does not exacerbate autoimmunity inSeveral explanations could have explained the phe-
nomenon of disease exacerbation in the B7-deficient normal NOD mice (data not shown). Furthermore, in a
series of studies in which B7-deficient mice were treatedNOD setting. First, we had observed previously that the
increased incidence and severity of diabetes in CD28- with anti-CD28 to provide surrogate costimulation,
some animals died of a disease similar to that observeddeficient NOD mice correlated with a profound deficit
in Th2 differentiation (Lenschow et al., 1996b). Thus, in the CTLA-4-deficient mice, but, importantly, the oth-
ers did not develop diabetes (data not shown). Finally,the exacerbation of diabetes in B7-deficient NOD mice,
which lack CD28 signaling, might have been related T cell proliferation to GAD, a unique and critical autoanti-
gen in diabetes, was not increased in B7-deficient miceto ineffective Th2 development, since previous studies
Immunity
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(data not shown), suggesting that the absence of mice perhaps through the production of TGFb or other
immunosuppressive cytokine.CTLA-4 ligation did not result in uncontrolled prolifera-
tion to this autoantigen. Interestingly, the absence of The profound decrease of the CD41CD251 regulatory
T cells in B7/CD28-deficient mice was unexpected. SuchCTLA-4 ligation in the B7-deficient NOD mice may explain,
at least in part, why Th2 differentiation was partially a deficit in these regulatory T cells and the delay/protec-
tion of diabetes obtained after reintroducing these cellsmaintained in B7-deficient mice but not in CD28-defi-
cient mice. Indeed, previous studies from our laboratory in the B7/CD28-deficient mice provide an explanation
for the increase of diabetes in these mice. It remains tousing blocking antibody to CTLA-4 have shown that
CTLA-4 blockade promotes Th2 development (Walunas be determined whether B7/CD28 costimulation plays a
critical role in the development of the CD41CD251 Tand Bluestone, 1998). Thus, CD28 and CTLA-4 signaling
have opposite effects on Th2 differentiation. cells in the thymus or in providing a survival signal in
the periphery. The thymically derived CD41CD251 cellsThe enhanced autoimmune disease in the CD28/B7
mice is best explained as a consequence of the elimina- represent a unique lineage and have the capacity to
expand in the periphery (Papiernik et al., 1998). Sincetion of the immunoregulatory CD41CD251CTLA-41 T
cell subset essential for the protection of NOD mice CD41CD251 cells are missing in IL-2-deficient mice (Pa-
piernik et al., 1998), the control of this cell subset byfrom establishment of autoimmunity. The existence of
a CD41 T cell population present in peripheral lymphoid CD28 costimulation could be mediated by its control of
IL-2 production. In this regard, short-term blockade oftissues of prediabetic NOD mice capable of suppressing
autoimmune diabetes has been known for 10 years B7/CD28 costimulation following in vivo administration
of CTLA4Ig for only 9 days induced a dramatic decrease(Boitard et al., 1989). Moreover, a population of CD41
T cells constitutively expressing CD25 controls various of these cells. This result suggests that the homeo-
stasis of these cells is under a dynamic control of CD28autoimmune diseases such as gastritis or thyroiditis in
BALB/c mice (Asano et al., 1996; Suri-Payer et al., 1998; costimulation and supports the possibility that these cells
are encountering an ongoing signal in the periphery.Itoh et al., 1999). In addition, the present study demon-
strates that this population very efficiently controls auto- In conclusion, blocking B7 costimulation in vivo has
been shown to prevent or delay autoimmune diseasesimmune diabetes in NOD mice. The fact that splenocytes
from prediabetic mice depleted of the CD41CD251 T and graft rejection and is a promising alternative therapy
(Bluestone et al., 1999). However, the complex out-cells induced a rapid diabetes after transfer in NOD.SCID
mice suggests that they play a major role in regulating comes of such treatments must be carefully understood
and monitored. The critical role of CD28/B7 engagementthe switch from an islet nondestructive insulitis ob-
served in prediabetic mice to the massive islet destruc- in regulatory T cell homeostasis adds to a growing list of
ªunintendedº consequences of B7 blockade, including ation seen late in the progression of the disease. Interest-
ingly, in NOD mice a subpopulation of CD41 T cells selective defect of Th2 differentiation and increased T
cell proliferation by inhibiting CTLA-4 signaling. To-expressing high levels of CD62L present in the thymus
has been shown to play a regulatory role during the final gether, the results imply that immunomodulation of
spontaneous autoimmune diseases may not be easilyeffector phase of autoimmune diabetes (Herbelin et al.,
1998). These cells could be the precursors of the immu- altered by costimulation blockade due to the critical
importance of these pathways on the development andnoregulatory CD41CD251 T cells of peripheral lymphoid
tissues, since the latter cells derived from the thymus homeostasis of the regulatory T cell subset.
and most of them express high levels of CD62L (Thorn-
Experimental Procedureston and Shevach, 1998; Itoh et al., 1999). In addition,
the overall number of CD41CD251 T cells is reduced by
Mice
a factor of 1.5 in NOD mice as compared to other mouse B7-deficient mice (Borriello et al., 1997) were backcrossed to NOD
strains (data not shown). This reduction could be a factor mice for four generations and then intercrossed to generate B72/2,
in the susceptibility of NOD mice to autoimmunity. B71/2, and B71/1 NOD mice. CD28-deficient mice (Shahinian et al.,
1993) were backcrossed to NOD mice for 12 generations and thenThe regulatory CD41CD251 T cells were the only cells
intercrossed to generate CD281/1, CD281/2, and CD282/2 NOD mice.observed to be CTLA-41 in NOD mice (Figure 4). Thus,
The genotypes were determined by PCR using B7- and CD28-spe-CTLA-4 may play a critical role in regulating this disease
cific primers. NOD mice were purchased from the Jackson Labora-
by functioning through the suppressor T cell population. tory or Taconic. Typically, diabetes incidence at 24 weeks in our
Two pieces of recent data support this interpretation. animal facility is 70% in females and 20% in males with NOD mice.
First, Bachmann and colleagues have recently shown
Assessment of Diabetes and Insulitisthat addition of bone marrow from wild-type CTLA-4
Starting at 8 weeks of age, blood glucose levels were measuredsufficient mice protected CTLA-4-deficient mice from
every week with a Lifescan glucose meter (One Touch II, Lifescan,the lethal hyperproliferative disease (Bachmann et al.,
Milpitas, CA). Mice were considered diabetic after two consecutive
1999). It is possible that the bone marrow allows the measurements over 300 mg/dl. The onset of diabetes was dated
generation of a CTLA-41 regulatory cell that controls from the first of the sequential diabetic measurement. The scoring
the autoimmunity. Second, a recent study showed that of islets for an inflammatory response was performed as follows.
Pancreases were fixed in 3.7% paraformaldehyde and embeddedligation of CTLA-4 can induce the production of TGFb
in paraffin. For each animal, multiple 4 mm sections were prepared,(Chen et al., 1998), a potent immune regulatory cytokine
stained with hematoxylin and eosin, and scored blindly for severityof T cell activation and autoimmune diabetes (King et
of insulitis. The insulitis was considered peri-insulitis when lympho-
al., 1998). Thus, we would speculate that a CTLA-41 T cytes were found surrounding but not infiltrating the architecture of
cell, represented in the CD41CD251 regulatory T cell the islets. Insulitis was considered as moderate if less than half of
the islet architecture was infiltrated with lymphocytes and severe ifsubset, may control autoimmune diabetes in the NOD
CD28 Controls Regulatory T Cell Homeostasis
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more than half of the islet architecture was infiltrated with lympho- Depletion of CD41CD251 Cells and Cell Transfer
in NOD.SCID micecytes.
Spleen cells, depleted of red blood cells, were incubated with anti-
CD25 mAb (25% supernatant of 7D4 hybridoma, ATCC CRL-1698,
Antibodies and Recombinant Reagents ATCC), then cells expressing CD25 were depleted with rabbit com-
Anti-CD3 mAb (145±2C11 [Leo et al., 1987]) and anti-CTLA-4 (UC10± plement during an incubation of 45 min at 378C. Dead cells were
4F10 [Walunas et al., 1994]) were purified over a protein A±coupled removed after a Ficol-Hypaque gradient; viable cells were washed
Sepharose column. Biotin-labeled anti-CD25 mAbs (7D4) and FITC- once with culture medium and twice with 13 PBS, and injected in
labeled anti-CD4 mAb (GK1.5) were obtained from Southern Bio- the retroorbital blood sinus of NOD.SCID mice. The depletion of
technology Associates (Birmingham, AL). PE-labeled anti-CD25 CD41CD251 cells was checked by flow cytometry using the anti-
mAbs (PC61) were purchased from PharMingen (San Diego, CA). CD25 antibodies produced by the PC61 hybridoma, which does not
The murine CTLA4Ig was kindly provided by Genetics Institute (Cam- compete for the binding of CD25 with the mAb produced by the
bridge, MA). 7D4 hybridoma that was used for complement depletion. Typically,
less than 0.1% of the depleted cells expressed CD25.
Flow Cytometry Analyses
Purification of CD41CD251 and CD252 T Cells and Cell TransferFor determination of the proportion of CD41CD251 cells, 1 3 106
The CD41CD251 cells were purified using a technique derived fromspleen cells or lymph node cells were washed in FACS buffer (0.1%
a protocol previously described (Thornton and Shevach, 1998). CellsBSA and 0.01% sodium-azide in 13 PBS), incubated at room tem-
from axillary, brachial, inguinal, cervical, mandibular, and mesentericperature with 20% hybridoma supernatant of anti-FcgR mAb (2.4G2,
lymph nodes of 6- to 12-week-old NOD males were mechanicallyATCC HB-197, ATCC, Manassas, VA) for 10 min, then incubated for
dissociated, and cells expressing CD8 (CD81 T cells) and CD2430 min at 48C with saturating amounts of FITC-coupled anti-CD4
(antigen-presenting cells) were depleted with rabbit complement at(GK1.5, PharMingen) and biotin-coupled anti-CD25 (7D4, Phar-
37oC for 30 min. After a Ficol-Hypaque gradient to remove deadMingen), washed in FACS buffer, and revealed with PE-coupled
cells, purified CD41 T cells were cultured overnight at 3 3 106 cellsstreptavidin (Southern Biotechnology Associates) by staining 30 min
per milliliter in culture medium (see above) supplemented with 20at 48C. After a final wash, cells were analyzed on a FACScan flow
U/ml recombinant murine IL-2 (Cetus, Emeryville, CA). Followingcytometer (Becton Dickinson, Mountain View, CA).
incubation, the cells were washed twice to remove any remainingFor analysis of intracellular CTLA-4, splenocytes were first stained
IL-2 and stained with 0.5 mg biotin-coupled anti-CD25 mAb (7D4)in FACS buffer with PE-labeled anti-CD4 and biotin-labeled anti-
per 1 3 106 cells, followed by a staining with 0.1 mg FITC-coupledCD25 revealed with PercP-coupled streptavidin, fixed with 1% PFA
streptavidin (Southern Biotechnology Associates) per 1 3 106 cells.for 10 min at room temperature, washed with PBS containing 0.03%
The stained cells were incubated with anti-FITC microbeads (Mil-saponin, stained with 1 mg anti-CTLA-4 and 1% goat serum in per-
tenyi Biotec, Auburn, CA) for 30 min on ice, washed, and CD251meabilizing buffer (PBS containing 0.3% saponin), washed, and re-
cells were separated on a VS1 positive selection column (Miltenyivealed with a FITC-labeled goat anti-hamster antibody in permeabil-
Biotec). The purity of the CD41CD251 cells was z85%. Theizing buffer. For control staining, cells were similarly stained except
CD41CD252 T cells, which did not bind to the anti-CD25-coatedthat a control hamster antibody was used in the absence of the
beads, were harvested from the flow through during the washinganti-CTLA-4 mAb.
steps. In some experiments, CD252 T cells were purified from lymph
nodes after depletion of CD241 and CD251 cells with rabbit comple-
T Cell Stimulation Assay and Cytokine Detection ment. Purified T cells were washed twice in 13 PBS and injected in
Spleen cells, depleted of red blood cells, were cultivated at 1 3 the retroorbital blood sinus of CD28-deficient mice or of NOD.SCID
106 per milliliter in a 24-well plate in culture medium (DMEM [Life mice as described in the figure legends.
Technologies, Grand Island, NY] supplemented with glutaMAX, 5%
FCS [Summit Biotechnology], antibiotics, 10 mM HEPES, and 5 3 Acknowledgments
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